Condition
Antioxidant Capabilities
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07395921Not ApplicableNot Yet Recruiting
Resveratrol Effects on Inflammatory Biomarkers and Cardiometabolic Parameters.
NCT06657963Not ApplicableCompletedPrimary
Effects of Opuntia Ficus-indica Supplementation on Antioxidant Status and Inflammation Levels
NCT02177383Not ApplicableCompleted
Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance
Showing all 3 trials